Breaking News Instant updates and real-time market news.

TEVA

Teva

$30.76

0.06 (0.20%)

06:59
04/21/17
04/21
06:59
04/21/17
06:59

Teva risk/reward favorable at current share levels, says Citi

Citi analyst Liav Abraham views Teva's risk/reward profile as favorable at current share levels. The analyst's analysis suggests some upside to consensus FY17 generics estimates. Abraham acknowledges investor caution ahead of the new CEO announcement, and lowered her price target for the shares to $42 from $47, but she keeps a Buy rating on Teva.

  • 04

    May

  • 11

    May

  • 30

    Aug

TEVA Teva
$30.76

0.06 (0.20%)

04/12/17
LEER
04/12/17
NO CHANGE
Target $68
LEER
Outperform
Neurocrine Valbenazine approved with 'best case,' says Leerink
Following Neurocrine's (NBIX) announcement of FDA approval of Ingrezza, or valbenazine, for adults with Tardive Dyskinesia, Leerink analyst Paul Matteis says that the language in the label looks to be a best-case scenario for the company as it outlines few safety risks and does not contain a black box warning for increased risk of suicidality. The analyst believes the latter adds to valbenazine's advantages over Teva's (TEVA) SD-809. Matteis moved his odds of FDA approval from 90% to 100%, reiterated an Outperform rating on Neurocrine's stock and raised his price target on the shares to $68 from $65.
04/12/17
JEFF
04/12/17
NO CHANGE
Target $43
JEFF
Buy
Jefferies views Alder concerns as overblown, sees buying opportunity
After spending time with an intellectual property expert, Jefferies analyst Brian Abrahams believes IP concerns relating to Alder Biopharmaceuticals (ALDR) remain overdone. He does not believe Teva's (TEVA) patents will be upheld as valid in the U.S. Abrahams does not think IP conflicts would dissuade potential partners and/or acquirers and keeps a Buy rating on Alder with a $43 price target. The analyst sees a buying opportunity at current levels into the Phase III data.
04/06/17
OPCO
04/06/17
NO CHANGE
Target $43
OPCO
Outperform
Teva Austedo approval 'a nice incremental positive,' says Oppenheimer
Oppenheimer analyst Derek Archila notes that Teva (TEVA) received approval for Austedo for Huntington's chorea, which he sees as "a nice positive" given the company's recent challenges. Based on his review of the label and recent physician checks, the analyst believes Austedo could potentially become first-line therapy for Huntington's chorea and forecasts sales of about $600M by 2022 in this indication. Archila continues to like Teva's shares long term, though he expects they may be range-bound until a new CEO is hired, generic business stabilizes, and Allergan's (AGN) stake in Teva is resolved. He reiterates an Outperform rating and $43 price target on Teva's shares.
03/07/17
JEFF
03/07/17
NO CHANGE
Target $33
JEFF
Buy
Supernus settlement modestly better than expected, says Jefferies
Jefferies analyst David Steinberg says Supernus Pharmaceuticals (SUPN) should be able maintain exclusivity on 65% of Trokendi XR sales until January 2023 following its settlement with Zydus Pharmaceutical. The analyst views the settlement as modestly better than his forecast. Should Supernus secure a similar settlement with Teva (TEVA), it would be well positioned to transition the revenue stream from its current epilepsy franchises to two late-stage pipeline candidates, Steinberg tells investors in a research note. He keeps a Buy rating on Supernus with a $33 price target.

TODAY'S FREE FLY STORIES

16:39
06/23/17
06/23
16:39
06/23/17
16:39
General news
Moody's raises Greece rating to Caa2 from Caa3, outlook to positive from stable »

Moody's has upgraded…

CFCO

CF Corporation

$11.42

-0.04 (-0.35%)

16:38
06/23/17
06/23
16:38
06/23/17
16:38
Hot Stocks
Breaking Hot Stocks news story on CF Corporation »

Mason Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKS

AK Steel

$6.65

0.35 (5.56%)

, X

U.S. Steel

$22.25

1.18 (5.60%)

16:34
06/23/17
06/23
16:34
06/23/17
16:34
General news
On The Fly: Top stock stories for Friday »

Stocks opened in quiet…

AKS

AK Steel

$6.65

0.35 (5.56%)

X

U.S. Steel

$22.25

1.18 (5.60%)

PTLA

Portola Pharmaceuticals

$56.13

17.88 (46.75%)

BAC

Bank of America

$22.82

-0.11 (-0.48%)

C

Citi

$63.41

-0.21 (-0.33%)

GS

Goldman Sachs

$217.19

-2.58 (-1.17%)

JPM

JPMorgan

$86.86

-0.16 (-0.18%)

MS

Morgan Stanley

$43.69

-0.92 (-2.06%)

WFC

Wells Fargo

$52.45

-0.04 (-0.08%)

SNCR

Synchronoss

$16.24

4.06 (33.33%)

BBBY

Bed Bath & Beyond

$29.65

-4.09 (-12.12%)

BBRY

BlackBerry

$9.71

-1.35 (-12.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 23

    Jun

  • 23

    Jun

  • 24

    Jun

  • 26

    Jun

  • 29

    Jun

  • 14

    Jul

  • 14

    Jul

  • 18

    Jul

  • 25

    Jul

  • 25

    Jul

  • 12

    Oct

  • 12

    Oct

  • 17

    Oct

  • 15

    Jan

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

FMC

FMC Corporation

$74.78

0.52 (0.70%)

16:31
06/23/17
06/23
16:31
06/23/17
16:31
Hot Stocks
FMC Corporation to sell Omega-3 business to Pelagia AS, terms not disclosed »

FMC Corporation has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
06/23/17
06/23
16:30
06/23/17
16:30
Options
Preliminary option volume of 15.0M today »

Preliminary option volume…

ESNC

EnSync

$0.33

0.0151 (4.79%)

16:25
06/23/17
06/23
16:25
06/23/17
16:25
Syndicate
Breaking Syndicate news story on EnSync »

EnSync files $25M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

PTLA

Portola Pharmaceuticals

$56.13

17.88 (46.75%)

16:25
06/23/17
06/23
16:25
06/23/17
16:25
Conference/Events
Portola Pharmaceuticals hold a conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 23

    Jun

  • 24

    Jun

DTE

DTE Energy

$108.89

-0.69 (-0.63%)

16:24
06/23/17
06/23
16:24
06/23/17
16:24
Earnings
DTE Energy backs FY17 operating EPS view $5.15-$5.46, consensus $5.33 »

DTE Energy will meet with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jul

$NSD

NASDAQ Market Internals

16:17
06/23/17
06/23
16:17
06/23/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VHI

Valhi Inc

$3.29

0.14 (4.44%)

16:16
06/23/17
06/23
16:16
06/23/17
16:16
Hot Stocks
Valhi Inc termiantes purchase deal for sale of Waste Control Specialists »

As previously announced,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

16:16
06/23/17
06/23
16:16
06/23/17
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBL

GAMCO Investors

$29.63

-0.24 (-0.80%)

, LSXMA

Liberty SiriusXM

$40.83

0.79 (1.97%)

16:14
06/23/17
06/23
16:14
06/23/17
16:14
Hot Stocks
Breaking Hot Stocks news story on GAMCO Investors, Liberty SiriusXM »

Gabelli reports 5.22%…

GBL

GAMCO Investors

$29.63

-0.24 (-0.80%)

LSXMA

Liberty SiriusXM

$40.83

0.79 (1.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WETF

WisdomTree

$9.98

-0.11 (-1.09%)

16:13
06/23/17
06/23
16:13
06/23/17
16:13
Hot Stocks
WisdomTree to close, liquidate three ETFs »

WisdomTree announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CONN

Conn's

$17.10

0.15 (0.88%)

16:11
06/23/17
06/23
16:11
06/23/17
16:11
Hot Stocks
Breaking Hot Stocks news story on Conn's »

Point72 Asset reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Wal-Mart

$74.87

-0.655 (-0.87%)

, WFM

Whole Foods

$42.95

-0.255 (-0.59%)

16:11
06/23/17
06/23
16:11
06/23/17
16:11
Periodicals
Wal-Mart not weighing offer for Whole Foods, Reuters reports »

Wal-Mart (WMT) is not…

WMT

Wal-Mart

$74.87

-0.655 (-0.87%)

WFM

Whole Foods

$42.95

-0.255 (-0.59%)

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

APDN

Applied DNA Sciences

$1.09

0.06 (5.83%)

16:10
06/23/17
06/23
16:10
06/23/17
16:10
Hot Stocks
Applied DNA Sciences receives order to tag 27.5M pounds of cotton »

Applied DNA Sciences is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOCO

Mocon

16:08
06/23/17
06/23
16:08
06/23/17
16:08
Hot Stocks
Gabelli liquidates stake in Mocon »

As a result of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TKTDY

Takata

$3.15

1.2199 (63.21%)

16:03
06/23/17
06/23
16:03
06/23/17
16:03
Periodicals
Takata to seek bankruptcy protection as soon as Sunday, WSJ reports »

Takata intends to seek…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIPT

Tiptree Financial

16:02
06/23/17
06/23
16:02
06/23/17
16:02
Hot Stocks
Tiptree Financial repurchases 1M shares from Nomura Securities »

Tiptree has repurchased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFBC

Preferred Bank

16:01
06/23/17
06/23
16:01
06/23/17
16:01
Hot Stocks
Preferred Bank raises quarterly dividend 11% to 20c per share »

Preferred Bank reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

16:01
06/23/17
06/23
16:01
06/23/17
16:01
Hot Stocks
Amgen receives positive CHMP opinion to expand use of Mimpara »

Amgen announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

  • 19

    Jul

  • 14

    Aug

  • 03

    Feb

WFM

Whole Foods

$43.20

-0.06 (-0.14%)

, WMT

Wal-Mart

$74.66

-0.86 (-1.14%)

15:56
06/23/17
06/23
15:56
06/23/17
15:56
Periodicals
Wal-Mart not considering bid for Whole Foods, Reuters says 

Reuters cites a source.

WFM

Whole Foods

$43.20

-0.06 (-0.14%)

WMT

Wal-Mart

$74.66

-0.86 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$7.77

-0.03 (-0.38%)

, FTI

TechnipFMC

$26.69

-0.045 (-0.17%)

15:30
06/23/17
06/23
15:30
06/23/17
15:30
Periodicals
Petrobras seeks to change riser contract with TechnipFMC, Reuters reports »

Petrobras (PBR) is in…

PBR

Petrobras

$7.77

-0.03 (-0.38%)

FTI

TechnipFMC

$26.69

-0.045 (-0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

EZPW

EZCORP

$9.00

0.25 (2.86%)

15:22
06/23/17
06/23
15:22
06/23/17
15:22
Hot Stocks
Breaking Hot Stocks news story on EZCORP »

Rovida Advisors reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$140.55

0.57 (0.41%)

, RUT

Russell 2000 Index

15:22
06/23/17
06/23
15:22
06/23/17
15:22
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

The Russell 2000 (RUT) is…

IWM

iShares Trust Russell 2000 Index Fund

$140.55

0.57 (0.41%)

RUT

Russell 2000 Index

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.